Skip to main content
Home
  • Main Menu
  • Topics
    • Video
    • Provider
    • Payer
    • Pharma
    • Consumer
    • Investor

Regions

  • ANZ
  • ASIA
  • EMEA
  • Global Edition
North America

Apple, Eli Lilly, Evidation Health joint study suggests device sensors can spot cognitive decline

These data provide a proof of concept that Apple products and other consumer devices can play a role in monitoring or identifying disease symptoms.
By Dave Muoio
August 08, 2019
03:08 pm
Share

Sensors from consumer-grade devices like iPhones, Apple Watches, iPads and Beddit sleep monitors capture enough data to spot mild cognitive impairment or Alzheimer’s disease dementia, according to a new feasibility study conducted jointly by Apple, Eli Lilly and Company and Evidation Health researchers that was presented today at a research conference held in Anchorage, Alaska.

“Over the past few years, we’ve seen how data and insights derived from wearables and mobile consumer devices have enabled people living with health conditions, along with their clinicians, to better monitor their health,” Nikki Marinsek, data scientist at Evidation Health and the study’s first author, said in a statement. “We know that insights from smart devices and digital applications can lead to improved health outcomes but we don’t yet know how those resources can be used to identify and accelerate diagnoses. The results of the trial set the groundwork for future research that may be able to help identify people with neurodegenerative conditions earlier than ever before.”

The 12-week Lilly Exploratory Digital Assessment Study was built on the back of Evidation’s platform for device-driven real-world data collection platform. In it, 31 participants aged 60 to 75 years with cognitive impairment and 82 without were provided with Apple’s devices and an assessment app. These products passively monitored the participants during their everyday lives, with questionnaires and psychomotor, reading and typing assessments delivered through the app rounding out the data collection.

After collecting and analyzing 16 terabytes of information, the team was able to identify several data-driven behavior characteristics associated with symptoms of cognitive decline. These included slower typing, daily first steps that were later or less regular, reduced texting, more time spent in helper apps and worse compliance with daily study surveys.

WHY IT MATTERS

These data provide a proof of concept that common consumer devices are collecting enough data to differentiate between users with or without cognitive decline, the researchers wrote. This suggests that a system could be devised that collects these data to monitor those with cognitive impairment or Alzheimer’s disease, or automatically flags individuals that may be developing these symptoms.

“Lilly has been leading the fight against Alzheimer’s disease for more than 30 years, and we’re broadening the application of digital health to identify tools that may improve the lives of people with chronic conditions and diseases,” Divakar Ramakrishnan, chief digital officer at Eli Lilly, said in a statement. “While further research is needed, the study findings provide important insight into the potential benefits of wearable devices in identifying chronic health conditions such as MCI, Alzheimer’s disease, and dementia. These findings could inform subsequent research that may eventually lead to early screening or detection tools for neurodegenerative conditions.”

Not to be overlooked, however, are the study collaborators themselves. It’s little secret at this point that Apple is very interested in digital health, but a relationship with pharma mainstay Eli Lilly is another concrete step down that pathway. Likewise, the collaboration also another vote of confidence for Evidation and its device-driven real-world data platform.

“We are excited to work alongside Lilly and Evidation in supporting the research community, as they seek to discover digital biomarkers of cognitive impairment,” Myoung Cha, Apple’s head of health strategic partnerships, said in a statement.

THE LARGER TREND

Eli Lilly and Evidation’s relationship has already been well publicized, with the two broadening the scope of their multi-year partnership back in December. And Apple is no stranger to research partnerships with pharmas — earlier this year the company announced another program with Johnson & Johnson focused on the Apple Watch’s potential role in senior health monitoring.

Tags: 
Apple, Eli Lilly, Eli Lilly and Company, Evidation Health, Evidation, cognitive decline, Alzheimer's Disease, consumer devices, device sensors, real-world data

More regional news

Pharmacist interacting online

Serve You Rx, Amazon Pharmacy partner for home delivery

By
Anthony Vecchione
May 02, 2025
Two people shaking hands with six others watch

DarioHealth closes up to $50M debt refinancing and more funding news

By
Jessica Hagen
May 02, 2025
Smart phone and smart watch

Oura and Google Fitbit partner with academia and others to battle opioid disorder

By
Anthony Vecchione
May 02, 2025
Share

Top Story

Smart phone and smart watch
Oura and Google Fitbit partner with academia and others to battle opioid disorder

Editor's Pick

23andMe files for bankruptcy, CEO Wojcicki resigns
Q&A: Oura appoints its first chief medical officer
First blood pressure management system integrated with DeepSeek in Hong Kong
Emirates will offer inflight telemedicine aboard 300 aircraft
Nanowear announces partnership with Dexcom
Navina raises $55M to expand AI for value-based care

More Stories

Pharmacist interacting online
Serve You Rx, Amazon Pharmacy partner for home delivery
Two people shaking hands with six others watch
DarioHealth closes up to $50M debt refinancing and more funding news
Nurse consulting with patient
Teton unveils 3D hospital digital twin using Denmark's supercomputer
Young person communicating with a cell phone
Talkspace, Bark Technologies partner to monitor children's online activities
Pharmacist giving a person an injection
Plenful scores $50M and more funding news
Person interacting with a healthcare professional via tablet
Teladoc acquires UpLift for $30M, releases first quarter results
Person in a pharmacy setting
Hims & Hers, Novo Nordisk partner to offer weight-loss drug Wegovy
Healthcare professional looking at a PC screen
Commure, HealthTap partner for expanded after-hours care
Home

More News

  • Healthcare IT News
  • Healthcare IT News Australia
  • Healthcare Finance News
  • HIMSS TV

MobiHealthNews

 

Connect

Add MobiHealthNews to your network.
HIMSS25 European Health Conference & Exhibition
HIMSS25 European Health Conference & Exhibition
Get ready for knowledge-sharing, all the latest innovations, and in-depth demos with Europe's most influential healthcare community.
10 - 12 June, 2025 | Paris
Learn More
AI in Healthcare Forum
AI in Healthcare Forum
The HIMSS AI in Healthcare Forum cuts through the hype to showcase real-world examples illustrating the transformative potential, and realistic challenges of AI application across the care continuum.
10 - 11 July 2025 | New York
Learn More

Footer Menu

  • About
  • Advertise
  • Reprints
  • Contact
  • Privacy Policy

© 2025 MobiHealthNews is a publication of HIMSS Media

X

Topics

  • Video
  • Provider
  • Payer
  • Pharma
  • Consumer
  • Investor

Career

  • Events
  • Jobs
  • Learning Center

More

  • About
  • Advertise
  • Contact
  • Privacy Policy

Regions

  • ANZ
  • ASIA
  • EMEA
  • Global Edition

MobiHealthNews:

The latest news in digital health delivered daily to your inbox.

Search form

Top Stories

Smart phone and smart watch
Oura and Google Fitbit partner with academia and others to battle opioid disorder
Three surgeons operating on a patient
Thyroid cancer AI assistant developed in Hong Kong
A doctor discussing findings with an older patient
Digital dementia support project gets $2M federal funding and more briefs